Donate
  • Freedom
  • Innovation
  • Growth

In The News

Publication Type 
October 14, 2019

The NBA Kneeled to China

A hysterical over-reaction to something small does not show how strong someone is. It shows how weak and insecure they are.

October 10, 2019

Trump Impeachment Efforts Will Haunt the Next Democrat In the White House

Democrats will regret setting into motion the never-ending impeachment process.

October 8, 2019

The US Shale Oil Boom Has Made A Middle East War Less Likely

It looks like the decade-old U.S. shale oil boom may keep us out of war.

October 7, 2019

Incriminating Photo Bad News for Biden

IPI expert referenced: Merrill Matthews | Media Hit

A political scholar believes the controversy surrounding Joe Biden's son could weigh down on the former vice president. 

October 4, 2019

Texas Cities' and Counties' Taxpayer-Funded Happy Hour Is Over - Almost

Every public official is supposed to understand the necessity of caring for taxpayer money.

October 3, 2019

Warren Takes the Lead

IPI expert referenced: Merrill Matthews | Media Hit

Political scholar Dr. Merrill Matthews of IPI says three main factors contribute to Elizabeth Warren's rise in the Democratic presidential polls.

October 1, 2019

Giovanetti: Court Ruling on Title II Repeal 'Great for Markets, Ecommerce, Internet Freedom'

The DC Circuit Court of Appeals has validated the FCC's ‘Restoring Internet Freedom Order,’ which restores the longtime ‘light touch’ regulatory approach to the internet. 

September 27, 2019

Why Warren Is Taking the Lead

For voters who want socialist policies but conclude Sanders cannot win the nomination Warren is the next best option.

September 24, 2019

GOP, Progressives, Insurers - All Cast Skeptical Eye at Pelosi Drug Plan

IPI expert referenced: Merrill Matthews | Media Hit

House Speaker Nancy Pelosi (D-Calif.) formally released her long-awaited drug-pricing bill last week, and very few individuals and organizations endorsed it outright. 

September 23, 2019

Where Trump and Pelosi Can Come Together on Drug Prices - and Where They Can't

Trump’s motivation combined with some degree of real agreement on policy issues suggest that lawmakers could find a way to craft legislation aimed at controlling drug prices. But there are still plenty of reasons to think the effort will go nowhere.

Total Records: 1688